32
total announcements
NIVABUPA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹14,536 Cr
P/E (TTM)
40.3
P/E (Forward)
23.6
EPS (TTM)
₹1.95
52W Low
₹67.50
52W High
₹91.40
Dividend Yield
0.00%
Price / Book
3.8
Return on Equity
12.14%
Debt / Equity
6.8
Revenue (TTM)
₹8,983 Cr
Gross Margin
11.25%
Operating Margin
7.81%
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Outcome of Debt Raising Committee Meeting held on October 09, 2026, where the committee approved the exercise of call option and record date in relation to 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures aggregating to ₹ 1,50,00,00,000/-.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming no demat requests for the quarter ended September 30, 2026.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange about the schedule of an institutional investor meet, which will be held on September 24, 2026, at 6:00 P.M. IST via a virtual call.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has been assigned a Financial Strength Rating of A- (Excellent), a Long-Term Issuer Credit Rating of “a-” (Excellent) and an India National Scale Rating (NSR) of aaa.IN (Exceptional) by AM Best, a global credit rating agency.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding a change in Management of the Company effective September 16, 2026, with Mr. Vikas Jain transitioning to a new role as Chief Transformation Officer and Mr. Karan Bhatia appointed as Chief Investment Officer.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding a change in Management of the Company effective September 16, 2026. Mr. Vikas Jain, Chief Investment Officer, will be transitioning into a new role as Chief Transformation Officer, and Mr. Karan Bhatia has been appointed as Chief Investment Officer.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has received an ESG rating of '67 Leader' for FY 2024-25 & FY 2025-26 from Niche99 ESG Ratings, a SEBI-registered ESG Rating Provider.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has allotted 4,11,000 equity shares under its ESOP schemes, increasing its paid-up equity share capital to ₹18,49,64,47,030.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has received credit ratings from ICRA Limited, reaffirming the issuer rating at [ICRA]AAA (Stable) and assigning a subordinated debt rating of [ICRA]AA+(Stable) for a proposed sub-debt of up to ₹500.00 crores.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has received an order from the Insurance Regulatory and Development Authority of India (IRDAI) for not complying with the applicable Expense of Management (EoM) limits for the FY 2024-25. The Company has been warned and directed not to open new places of business for a period of six months.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has submitted the Scrutinizer's Report on e-voting for its 18th Annual General Meeting held on August 12, 2026, confirming that the resolutions proposed in the Notice of AGM were passed with the requisite majority.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited held its 18th Annual General Meeting (AGM) on August 12, 2026, through video conferencing facility. The meeting was attended by the directors, company secretary, and representatives of the joint statutory auditors and secretarial auditor. The AGM was conducted in accordance with the applicable provisions of the Companies Act, 2013, and SEBI Listing Regulations. The reports of the joint statutory auditors on financial statements and the secretarial audit report were confirmed, and no qualifications, observations, or adverse remarks were found.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has received approval from IRDAI for the appointment of Mr. Ashwani Bhatia as the Chairperson of the company, effective June 3, 2026.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange about the transcript of the Earnings call on the business performance of the Company for the quarter ended June 30, 2026, held with Investors/Analysts on July 30, 2026.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has submitted a copy of newspaper publication pertaining to its unaudited financial results for the quarter ended June 30, 2026, as required by Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange about the link to the recording of their earnings conference call for the quarter ended June 30, 2026.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited reported a Profit After Tax (PAT) of ₹138 crore, registering a robust 93% year-on-year growth. The company sustained its healthy growth momentum in the first quarter, reporting Gross Written Premium (GWP) of ₹2,150 crore, up 32%. Niva Bupa's retail health business registered a robust 47% growth, contributing to an increase in Retail Health Market Share to 11.1%.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange about Investor Presentation for Q1'FY2027, highlighting a 31.7% y-o-y growth in GWP to ₹ 2,150 crore and a near-doubling of PAT to ₹ 137.8 crore.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding the outcome of its Board meeting, where it approved the issuance of non-convertible debentures worth up to ₹500 crores on a private placement basis.